Call for caution for using a CAR-T immunotherapy against acute myeloid leukemia

(Josep Carreras Leukaemia Research Institute) Researchers from the Josep Carreras Leukaemia Research Institute prove that the preclinical implementation of Acute Myeloid Leukaemia immunotherapy, based on CD123-redirected CAR T-cells, affects hematopoiesis, blood cells production, and reconstitution.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news